Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
77 hedge funds and large institutions have $106M invested in Kindred Biosciences, Inc. in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 8 closing their positions.
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
36% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 22
3% more funds holding
Funds holding: 75 → 77 (+2)
52% less capital invested
Capital invested by funds: $220M → $106M (-$114M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.46M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.33M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$620K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$571K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$425K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$510K |
| 2 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$471K |
| 3 |
Millennium Management
New York
|
-$401K |
| 4 |
Squarepoint
New York
|
-$348K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$298K |
KIN Hedge Fund Activity: Q1 2020 in Review
77 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q1 2020, worth a combined $106M — down 52% from $220M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new KIN positions and 8 closed out — a net gain of 4 holders — while 30 added to existing stakes and 22 trimmed.
The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $2.46M. The largest seller was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, cutting an estimated $510K.
- 77 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q1 2020, up from 75 in Q4 2019.
- Funds reported $106M of Kindred Biosciences, Inc. stock for Q1 2020, down 52% quarter-over-quarter.
- 12 funds opened new Kindred Biosciences, Inc. positions in Q1 2020 and 8 closed out, a net change of +4 holders.
- The largest Kindred Biosciences, Inc. buyer in Q1 2020 was Assenagon Asset Management, an estimated $2.46M added.
- The largest Kindred Biosciences, Inc. seller in Q1 2020 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $510K sold.
Based on aggregated 13F filings for Q1 2020.